SEC Form 4 research
| Issuer | Artiva Biotherapeutics, Inc. |
|---|---|
| Tickers | ARTV |
| Reporting owners | 37 |
| Officers and directors | 8 |
| Last public filing | 2026-10-07 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-10-06 | Aslan Fred | S | 23,463 | $7.2 | Not reported |
| 2026-10-06 | 2026-10-05 | Horan Christopher | S | 10,340 | $6.84 | Not reported |
| 2026-10-06 | 2026-10-05 | Bush Jennifer | S | 8,370 | $6.84 | Not reported |
| 2026-10-06 | 2026-10-05 | Banerjee Subhashis | S | 1,099 | $6.84 | Not reported |
| 2026-10-06 | 2026-10-05 | Aslan Fred | S | 61,696 | $6.84 | Not reported |
| 2026-09-15 | 2026-09-15 | Aslan Fred | A | 110,000 | $0 | Not reported |
| 2026-09-15 | 2026-09-15 | Aslan Fred | A | 315,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-10 | Aslan Fred | A | 45,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-10 | Aslan Fred | A | 155,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-10 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., RA Capital Nexus Fund, L.P., Shah Rajeev M. | A | 16,250 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.